FIXX Homology Medicines, Inc.
Homology Medicines, Inc. (FIXX) is expected to report earnings on October 6, 2026, after the market close.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Homology Medicines, Inc.
Homology Medicines Inc. is a genetic medicines company. Its platform offers human hematopoietic stem cell derived adeno-associated virus vectors to treat disease-causing mutations through gene correction, insertion and knockout. Homology Medicines Inc. is based in BEDFORD MA.
Sector
Healthcare
Charts powered in part by Lightweight Charts™ by TradingView.